BridgeMD
New treatment option for Crohn Disease
Official title Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group
ClinicalTrials.gov ID: NCT03458195
What this study is testing
- What it's testing
- Crohn's disease (CD), a chronic inflammatory process in intestinal segments leads to tissue damage. More than two thirds of CD patients need intestinal resection.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Informed consent obtained before any study-related activities
- A diagnosis of CD, based on clinical, radiologic, endoscopic, or histological evidence.
- Men and women ≥18 years of age
- Required surgical intervention consisting in an ileocecal resection
You likely can't join if
- Previous history of dysplasia or cancer in the ileum or colon
- Unwillingness or inability to follow the procedures outlined in the protocol
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Liège, Belgium
- Amiens, France
- Bordeaux, France
- Clermont-Ferrand, France
- Clichy, France
- Créteil, France
- Le Kremlin-Bicêtre, France
- Lille, France
- Marseille, France
- Montpellier, France
- Nancy, France
- Nantes, France
- Nice, France
- Paris, France
- Pierre-Bénite, France
- Strasbourg, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Liège, Belgium; Amiens, France; Bordeaux, France; Clermont-Ferrand, France; Clichy, France; Créteil, France and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.